Arno Therapeutics
Financial ratios & Valuation

Historical Multiples (2012 – 2022)

2012 2013 2014 2015 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.81-0.361.74-0.61N/AN/AN/AN/A-0.00-0.61
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-2.13-1.63-23.08-0.81N/AN/AN/AN/A-0.00-0.81
Price/Cash Flow ratio
-2.77-1.47-0.72-0.70N/AN/AN/AN/A-0.00-0.70
Price/Free Cash Flow ratio
-2.77-1.47-0.72-0.70N/AN/AN/AN/A-0.00-0.70
Price/Earnings Growth ratio
0.02-0.00-0.010.00N/AN/AN/AN/AN/AN/A
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A-46.82%0.00%-0.24%N/AN/AN/AN/AN/A-0.24%
Return on Assets
-111.60%-216.59%94.21%-3193.54%N/AN/AN/AN/A-581.39%-3193.54%
Return On Equity
117.29%451.94%-1319.55%133.76%N/AN/AN/AN/A232.32%133.76%
Return on Capital Employed
-112.34%-73.71%-352.89%346.61%N/AN/AN/AN/A-1335.77%N/A
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/A1.52N/A
Quick Ratio
3.376.863.800.07N/AN/AN/AN/A1.390.07
Cash ratio
3.376.863.680.01N/AN/AN/AN/A1.390.01
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A48.34KN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
1.95N/AN/A5.78N/AN/AN/AN/A3.42N/A
Debt Equity Ratio
-2.05N/AN/A-0.24N/AN/AN/AN/A-1.41N/A
Long-term Debt to Capitalization
-0.04N/AN/AN/AN/AN/AN/AN/A-0.00N/A
Total Debt to Capitalization
N/AN/AN/A-0.31N/AN/AN/AN/A-0.00-0.31
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-261.86N/A
Cash Flow to Debt Ratio
-19.18N/AN/A-4.76N/AN/AN/AN/A-1.49KN/A
Company Equity Multiplier
-1.05-2.08-14.00-0.04N/AN/AN/AN/A-0.41N/A
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111.001N/AN/AN/AN/A1N/A
Cash Flow Coverage Ratio
N/AN/AN/A-4.76N/AN/AN/AN/A-1.49KN/A
Short Term Coverage Ratio
N/AN/AN/A-4.76N/AN/AN/AN/A-1.76KN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A